← SynDRA

MRS-1754

SynDRA canonical compound SYN0049573 — structure-anchored drug synonym record

All known targets

• ADORA2B
• ADORA1
• ADORA2A
• ADORA3

Mechanisms of action (all sources)

• Adenosine receptor antagonist
• ADORA1 ANTAGONIST
• ADORA2A ANTAGONIST
• ADORA2B ANTAGONIST
• ADORA3 ANTAGONIST

Cross-references

• PubChem CID: 6603931
• ChEMBL: CHEMBL273807
• ChEBI: 93269
• TTD: D01QYQ
• LINCS BRD: BRD-K72024482

Synonyms

• ATL-844
• CHEMBL273807
• MRS 1754
• MRS1754
• [<SUP>3</SUP>H]MRS1754
• N-(4-Cyanophenyl)-2-[4-(2,6-dioxo-1,3-dipropyl-7H-purin-8-yl)phenoxy]acetamide
• N-(4-Cyanophenyl)-2-[4-(2,3,6,7-tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8-yl)phenoxy]-acetamide
• [3H]MRS1754
• [3H]-MRS1754
• NCGC00015689-01
• Lopac-M-6316
• Lopac0_000729
• GTPL453
• GTPL449
• MLS002153324
• SCHEMBL1222380
• AC1O7G54
• CTK8E7916
• CHEBI:93269
• AOB5542
• DTXSID80424967
• MolPort-023-276-567
• HMS3373J21
• HMS3268F13
• HMS2230A06
• ZINC4475274
• BDBM50086170
• AKOS027427086
• AKOS024457276
• EX-3306
• ATL-618
• ATL-GW-22
• ATL-GW-8
• A2B adenosine receptor antagonists, Adenosine/Ortho-McNeil
• A2B adenosine receptor antagonists (oral, asthma/diabetes), Adenosine Therapeutics
• A2B adenosine receptor antagonists (oral, asthma/diabetes), Clinical Data
• 7E435V2DAH
• RefChem:827519